THE THYROPEROXIDASE DOUBLET IS NOT PRODUCED BY ALTERNATIVE SPLICING

Citation
F. Cetani et al., THE THYROPEROXIDASE DOUBLET IS NOT PRODUCED BY ALTERNATIVE SPLICING, Molecular and cellular endocrinology, 115(2), 1995, pp. 125-132
Citations number
26
Categorie Soggetti
Endocrynology & Metabolism","Cell Biology
ISSN journal
03037207
Volume
115
Issue
2
Year of publication
1995
Pages
125 - 132
Database
ISI
SICI code
0303-7207(1995)115:2<125:TTDINP>2.0.ZU;2-C
Abstract
Thyroperoxidase is a membrane-bound, heme-containing enzyme which cata lyses iodination of thyroglobulin and coupling of resulting iodotyrosi nes to produce thyroid hormone. In addition to the full length molecul e of 933 amino acids (TPO1), Northern blotting and sequencing have rev ealed several shorter transcripts. The most abundant is a species lack ing 171 nucleotides in which the alternative splicing results in the d eletion of codons 533-590 in exon 10 (TPO2). Evidence for TPO2 transcr ipts being translated into a protein is lacking, but in Western blots TPO invariably appears as a doublet of 110 and 105 kDa. In the present study we have produced two recombinant fusion proteins for: (i) the 5 7 amino acids which are spliced out in TPO2 and (ii) for the 20 amino acids which bridge the splice site (10 amino acids on both sides). Bot h recombinant fragments have been produced in the pMAL-cRI vector as a maltose-binding protein (MBP) fusion, permitting their purification f rom a bacterial lysate on an amylose column. Rabbits have been immuniz ed by intradermal injection of 500 mu g of fusion protein, initially i n complete Freund's adjuvant followed by two boosts, at 2-week interva ls, in incomplete Freund's adjuvant. The resulting high titre immune s era (IS) were reactive with the relevant immunising antigens, when tes ted by ELISA. Depletion of each serum by passage through an MBP-CNBr S epharose column allowed purification of antibodies against the relevan t peptides, as demonstrated by ELISA with the appropriate fusion prote in and MBP. This demonstrates that we have produced specific polyclona l antibodies for the 57 amino acids unique to TPO1 and for the amino a cid segment bridging the splice site, found in TPO2. These polyclonal antibodies were used in Western blotting experiments with normal and G raves' thyroid membranes, in reducing and non-reducing conditions. Mon oclonal 47/C21 which recognises a linear epitope (amino acids residues 710-722) common to TPO1 and TPO2 was used as a control. In non-reduci ng conditions, we observed a broad signal at 105-110 kDa, which appear ed to comprise two bands, with both polyclonal antibodies and the mono clonal. There was no difference in the image between the normal and th e Graves' thyroid. In reducing conditions, the broad signal resolved c learly into two distinct bands, one at 105 and the other at 110 kDa. O nce again we observed exactly the same pattern of reactivity with all three antibodies both in normal and Graves' glands. We conclude that t he TPO doublet is not the consequence of translation of TPO2.